Potential Therapeutic Targets and Promising Agents for Combating NAFLD

Nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), is a growing cause of liver cirrhosis and liver cancer worldwide because of the global increases in obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus. Contrary to the advancements in therapies fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Umemura, Atsushi, Kataoka, Seita, Okuda, Keiichiro, Seko, Yuya, Yamaguchi, Kanji, Moriguchi, Michihisa, Okanoue, Takeshi, Itoh, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032837/
https://www.ncbi.nlm.nih.gov/pubmed/35453652
http://dx.doi.org/10.3390/biomedicines10040901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032837/
https://www.ncbi.nlm.nih.gov/pubmed/35453652
http://dx.doi.org/10.3390/biomedicines10040901

Ejemplares similares